Rapid responses are electronic letters to the editor. They enable our users to debate issues raised in articles published on thebmj.com. Although a selection of rapid responses will be included online and in print as readers' letters, their first appearance online means that they are published articles. If you need the url (web address) of an individual response, perhaps for citation purposes, simply click on the response headline and copy the url from the browser window. Letters are indexed in PubMed.
Reduction in funding for neuroscience is most untimely in view of the
rising numbers of people living long enough to suffer dementia and other
There are solutions waiting for trial which can be of huge assistance to
the NHS and to sufferers whilst at the same time saving money. They won't
see the light of day if funds are cut now.
A good example is the potential treatment of AD with anti-virals
following the work of Matthew Wozniak and Ruth Itzhaki in Manchester.
Trial of this should be a priority.
Another example is the treatment of Parkinson's with a 'tonic' of
food additives and supplements which has resulted in some cases reporting
almost complete regression of symptoms - as if it was a nutrient
deficiency syndrome. Surely worthy of funding in view of the benefits
available. see www.brainhelp.info
Now is not the time for cuts - widen the field of view and fund new
work which will show value for money.
Wozniak MA, Itzhaki RF. (2010) Antiviral agents in Alzheimer's
disease: hope for the future? Therapeutic Advances in Neurological
Disorders 3, 141-52.
Developer of the Parkinson's Improvement Programme from which I receive no financial gain.